ArticleCell transplantation

Outcomes of Second Anti-CD19 CAR T-Cell Therapy (CART2) in Acute B Lymphoblastic Leukemia and the Impact of Allo-HSCT on Efficacy.

Qianwen Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.